Literature DB >> 498504

Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma.

F J Frey, B M Frey, L Z Benet.   

Abstract

The therapeutic response to and side effects of glucocorticoids will be better recognized and the recovery of the adrenals during the tapering of therapy with steroids better evaluated if endogenous and exogenous glucocorticoids are separately assessed. We describe a specific method for simultaneously measuring the concentrations of cortisone, cortisol, prednisone, and prednisolone in plasma by "high-pressure" liquid chromatography. The steroids, together with an internal standard, dexamethasone, are extracted from 1 mL of plasma with methylene chloride-ether, washed with acid and base, and separated isocratically on a normal-phase silica column with a mobile phase consisting of methylene chloride/tetrahydrofuran/methanol/glacial acetic acid (96.85/1/2.1/0.05 by vol) at a flow rate of 1.3 mL/min. The steroids are detected at 254 nm and quantitated by peak-height measurements; their retention times range from 6 to 20 min. The lower limits for routine detection of all four compounds is 10 microgram/L. The analytical recoveries are about 75%; the intra-day variability (CV) is 1 to 9%, and the inter-day variability 2 to 11%. Of 26 drugs and 20 steroids tested, only theophylline presents an interference problem.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498504

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  20 in total

1.  Steroid metabolism in liver transplant patients.

Authors:  R Venkataramanan; M L Huang; B Delamos; G J Burckart; R J Ptachcinski; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

2.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

3.  HPLC determination and clinical significance of serum prednisone in patients with nephrotic syndrome.

Authors:  Chun-Mei Chen; Yun-Cheng Xia; Xu-Guang Zhang; Can-Hui Peng; Fu-You Liu; You-Ming Peng; Lin Sun
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 4.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

5.  Pharmacokinetics of fluocortolone in man.

Authors:  U F Legler
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.

Authors:  F J Frey; M K Rüegsegger; B M Frey
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

7.  Prednisolone protein binding in renal transplant patients.

Authors:  P A Reece; A P Disney; I Stafford; J C Shastry
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

8.  Disposition of prednisone and prednisolone in the perfused rabbit liver: modeling hepatic metabolic processes.

Authors:  V G Hale; K Aizawa; L B Sheiner; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

9.  Alterations in prednisolone disposition as a result of time of administration, gender and dose.

Authors:  P J Meffin; P M Brooks; B C Sallustio
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

10.  Pharmacokinetics of betamethasone in healthy adults after intravenous administration.

Authors:  M C Petersen; R L Nation; W G McBride; J J Ashley; R G Moore
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.